Learning Objectives:
- Learning Objective 1: Understand the typical steps and regulatory oversight of vaccine clinical development
- Learning Objective 2: Understand the differences between FDA approval and emergency use authorization
- Learning Objective 3: Appreciate the unusual considerations for rapid vaccine development and deployment in the setting of an ongoing pandemic
Session date:
06/20/2024 - 12:00pm to 1:00pm CDT
Location:
P-117
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Doran Fink, MD, PhD